Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInsel Gruppe AG, University Hospital Bern

About this trial

Up to half of patients with pulmonary embolism (PE) suffer from impaired quality of life, reduced physical capacity, and symptoms like shortness of breath even three months after diagnosis, despite standard treatment with anticoagulation (blood thinners). The randomized RehabPE trial investigates whether an early, structured rehabilitation program with physical training and patient education can prevent such long-term effects.

The study includes hospitalized patients with acute symptomatic PE who are at increased risk of impaired quality of life three months after diagnosis. After informed consent, patients are randomly assigned to one of two groups: one receives an early 6-8-week, center-based rehabilitation program; the other receives standard follow-up care without rehabilitation. The intervention group completes 16-18 outpatient sessions of endurance and strength training, along with two education sessions covering the condition, treatment, and symptom management.

Over 180 days, changes in quality of life, physical exercise capacity, breathlessness, and psychological symptoms, and the time to return to work / usual daily activities will be monitored and compared between groups.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years

Hospitalization for objectively confirmed acute symptomatic PE, defined as intraluminal filling defect of a segmental or more proximal pulmonary artery on computed tomography pulmonary angiography (CTPA) or a high-probability ventilation-perfusion scintigraphy, and admission within the past 7 days

Increased risk for post-PE syndrome, defined as simplified Pulmonary Embolism Severity Index (sPESI) ≥1 point at the time of admission

Written informed consent

Disqualifiers

Contraindication to EBR (known unstable cardiac conditions like angina pectoris, severe valvular heart disease, or severe resting pulmonary hypertension)

Medical condition that clearly precludes participation in EBR (e.g., inability to walk, unstable joints, severe neurological impairment)

Recently completed (i.e., <6 months), ongoing, or planned in- or outpatient EBR, or planned supervised outpatient physiotherapy for any indication

Planned hospitalization during follow-up (e.g., elective surgery or inpatient chemotherapy)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Exercise-based rehabilitation program

    Other intervention

    Participants in the intervention group will receive a patient-tailored early (i.e., within 4 weeks of PE diagnosis) EBR program, comprising 16-18 sessions of supervised aerobic exercise and resistance/strength training at local outpatient rehabilitation centers, along with 2 PE-related educational sessions at 2 and 6 weeks of rehabilitation. Participants will receive comprehensive information on the purpose of EBR and each of its components, reassurance on its safety, and education on self-monitoring. Furthermore, physiotherapists will tailor the training based on specific capabilities, focusing on areas of weakness.

Treatment groups

160 Participants
are divided into 2 treatment groups
Group A: Early exercise-based rehabilitation (EBR)Active comparator 1 intervention
Group B: usual care (no rehabilitation)No intervention 0 interventions

Trial outcomes

Primary outcomes

1

Change in generic health-related quality of life (Physical Component Summary score; SF-36)

Change from baseline to day 90 after randomization in generic healt-related quality of life (HRQoL) assessed by the PCS score of the self-completed SF-36 questionnaire. The SF-36 consists of 36 questions measuring 8 domains (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health) and assesses generic HRQoL during the previous 30 days. The PCS score is obtained from all 8 domains and ranges from 0 to 100.

Time frame
From baseline to day 90 after randomization

Secondary outcomes

1

Change in generic health-related quality of life (Physical Component Summary score; SF-36)

Change from baseline to day 180 after randomization in the SF-36 Physical Component Summary score, ranging from 0 to 100 with higher scores indicating better HRQoL.

Time frame
From baseline to day 180 after randomization
2

Change in generic health-related quality of life (Mental Component Summary score; SF-36)

Changes from baseline to day 90 and to day 180 after randomization in the SF-36 Mental Component Summary score, ranging from 0 to 100 with higher scores indicating better HRQoL.

Time frame
From baseline to day 90 and to day 180 after randomization
3

Change in PE-specific health-related quality of life (PEmb-QoL)

Change from baseline to day 90 and to day 180 after randomization in PE-specific health-realted quality of life assessed by the self-completed PEmb-QoL questionnaire, which comprises 9 questions covering 6 domains, with scores ranging from 0 to 100. Total scores will be calculated based on the average of scores of all 6 domains.

Time frame
From baseline to day 90 and to day 180 after randomization
4

Change in physical exercise capacity (6 minute walking test)

Change in physical exercise capacity from baseline to day 90 and to day 180 after randomization will be measured by the 6 minute walking test (6MWT). Participants will be asked to walk as far as possible in 6 minutes along a flat corridor of at least 30 mesters under supervision, and the distance in meters will determine the 6MWD.

Time frame
From baseline to day 90 and to day 180 after randomization

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.